相关实验视频
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
乙型肝炎病毒的逆转录酶作为病毒DNA合成的蛋白质原料
1Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
Cell
|November 13, 1992
概括
在体外合成的乙型肝炎病毒聚合酶显示反转录酶活性. 这种酶启动DNA合成,并保持与DNA的共价连接,这是病毒DNA聚合酶的新发现.
科学领域:
- 生物化学 生物化学
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 乙型肝炎病毒 (hepadnaviruses) 通过RNA中间体的逆转录复制.
- 研究病毒DNA合成一直是具有挑战性的,因为在溶解和表达活性病毒聚合酶方面存在困难.
研究的目的:
- 为了证明在体外合成的hepadnavirus聚合酶的酶活性.
- 描述病毒DNA合成和原料利用的机制.
主要方法:
- 在体外翻译合成hepadnavirus聚合酶.
- 用于测量逆转录酶活性的测试.
- 对聚合酶-DNA相互作用的分析.
主要成果:
- 合成的hepadnavirus聚合酶表现出逆转录酶活性.
- 聚合酶作为DNA合成的原料.
- 聚合酶仍然与新生的DNA保持共价连接,这是RNA指导的DNA聚合酶中独特的特征.
结论:
- 活跃的hepadnavirus逆转录酶可以在体外表达,使详细的生物化学研究.
- 该酶独特的原始化机制为抗病毒疗法提供了潜在的点.
相关概念视频
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K